glp 1 agonist anesthesia Holding GLP-1 Agonists Prior to Elective Procedures Perioperative management of patients taking

A recent study from British Columbia, Canada, explored the effects of GLP-1 receptor agonists in nearly 11,000 patients with both autoimmune conditions and diabetes

Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB

17 who revealed 42% headache symptoms decline

The rising global prevalence of obesity and continuing trials and R&D investment in the sector are likely to fuel further growth

Vogeler T, McClain C, Evoy KE

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated